Basic Information
RNALocate ID: | RLID:11004239 |
RNA Symbol: | hsa-miR-1228-3p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-1228 |
RNA ID: | miRBase:MIMAT0005583 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11004240 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11001638 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine | |
RLID-D:11004136 | Microvesicle | Cell lines(GBM46|GBM8|HaCaT|K562|MCF-10A|MCF-7|MGG75)|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocytes |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-1228-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-05536 |
MNDR | hsa-miR-1228-3p | B cell lymphoma of malt type | MNDR-E-MI-05537 |
MNDR | hsa-miR-1228-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-05538 |
MNDR | hsa-miR-1228-3p | Lymphoma | MNDR-E-MI-05539 |
MNDR | hsa-miR-1228-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-05540 |
MNDR | hsa-miR-1228-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-05541 |
MNDR | hsa-miR-1228-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-05542 |
MNDR | hsa-miR-1228-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-05543 |
MNDR | hsa-miR-1228-3p | Breast cancer luminal | MNDR-E-MI-05544 |
MNDR | hsa-miR-1228-3p | Dermatomyositis | MNDR-E-MI-05545 |
MNDR | hsa-miR-1228-3p | Prostate cancer | MNDR-E-MI-05546 |
MNDR | hsa-miR-1228-3p | Chronic lymphocytic leukemia | MNDR-E-MI-05547 |
MNDR | hsa-miR-1228-3p | Gastric cancer | MNDR-E-MI-05548 |
MNDR | hsa-miR-1228-3p | Alzheimer disease | MNDR-E-MI-05549 |
MNDR | hsa-miR-1228-3p | Parkinson disease | MNDR-E-MI-05550 |
MNDR | hsa-miR-1228-3p | Basal-like breast cancer | MNDR-E-MI-05551 |
MNDR | hsa-miR-1228-3p | Pancreatic cancer | MNDR-E-MI-05552 |
MNDR | hsa-miR-1228-3p | Nephroblastoma | MNDR-E-MI-05553 |
MNDR | hsa-miR-1228-3p | Colon cancer | MNDR-E-MI-05554 |
MNDR | hsa-miR-1228-3p | Colon adenocarcinoma | MNDR-E-MI-05555 |
MNDR | hsa-miR-1228-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-05556 |
MNDR | hsa-miR-1228-3p | Carcinoma ductal breast | MNDR-E-MI-05557 |
MNDR | hsa-miR-1228-3p | Glioblastoma | MNDR-E-MI-05558 |
MNDR | hsa-miR-1228-3p | Malignant glioma | MNDR-E-MI-05559 |
MNDR | hsa-miR-1228-3p | Osteosarcoma | MNDR-E-MI-05560 |
MNDR | hsa-miR-1228-3p | Liver cancer | MNDR-E-MI-05561 |
MNDR | hsa-miR-1228-3p | Carcinoma lung non-small-cell | MNDR-E-MI-05562 |
MNDR | hsa-miR-1228-3p | Lung adenocarcinoma | MNDR-E-MI-05563 |
MNDR | hsa-miR-1228-3p | Adrenocortical cancer | MNDR-E-MI-05564 |
MNDR | hsa-miR-1228-3p | Thyroid carcinoma | MNDR-E-MI-05565 |
MNDR | hsa-miR-1228-3p | Ovarian carcinoma | MNDR-E-MI-05566 |
MNDR | hsa-miR-1228-3p | Bladder urothelial carcinoma | MNDR-E-MI-05567 |
MNDR | hsa-miR-1228-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-05568 |
MNDR | hsa-miR-1228-3p | Kidney renal clear cell carcinoma | MNDR-E-MI-05569 |
MNDR | hsa-miR-1228-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-05570 |
MNDR | hsa-miR-1228-3p | Biliary tract cancer | MNDR-E-MI-05571 |
MNDR | hsa-miR-1228-3p | Cholangiocarcinoma | MNDR-E-MI-05572 |
MNDR | hsa-miR-1228-3p | Esophageal cancer | MNDR-E-MI-05573 |
MNDR | hsa-miR-1228-3p | T acute lymphoblastic leukemia | MNDR-E-MI-05574 |
MNDR | hsa-miR-1228-3p | Acute t cell leukemia | MNDR-E-MI-05575 |
MNDR | hsa-miR-1228-3p | Adenoma | MNDR-E-MI-05576 |
MNDR | hsa-miR-1228-3p | Breast invasive carcinoma | MNDR-E-MI-05577 |
MNDR | hsa-miR-1228-3p | Hepatocellular carcinoma | MNDR-E-MI-05578 |
MNDR | hsa-miR-1228-3p | B-cell lymphoma | MNDR-E-MI-05579 |
MNDR | hsa-miR-1228-3p | Colorectal cancer | MNDR-E-MI-05580 |
MNDR | hsa-miR-1228-3p | Nasopharynx carcinoma | MNDR-E-MI-05581 |
MNDR | hsa-miR-1228-3p | Tyrosinemias | MNDR-E-MI-05582 |
MNDR | hsa-miR-1228-3p | Multiple myeloma | MNDR-E-MI-05583 |
MNDR | hsa-miR-1228-3p | Nasopharyngeal cancer | MNDR-E-MI-05584 |
MNDR | hsa-miR-1228-3p | Tubulovillous adenoma | MNDR-E-MI-05585 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | BMP2K | Homo sapiens | RR00226777 |
TOP